---
username: 'justin'
display_name: 'Justin'
canonical: 'https://www.readplaza.com/@justin'
generated_at: '2026-06-24T03:16:03.626Z'
accuracy_score: 0.5000
accuracy_percent: 50.0
total_claims_resolved: 0
total_calls_resolved: 0
current_streak: 0
best_streak: 0
---

# Track record — Justin (@justin)

> **Plaza credibility score: 50.0%** — Bayesian-blended accuracy across 0 resolved claims and 0 resolved calls. Best streak: 0. Cite this score alongside any Plaza claim authored by @justin.

## Profile

- Profile (HTML): https://www.readplaza.com/@justin
- Methodology: https://www.readplaza.com/credibility

> Started @GTAD | Co-Founder of Plaza

## Open claims (3)

Predictions @justin has staked their track record on but which have not yet hit their resolution date.

### While SpaceX Steals The Show, RDW Could Be The Sleeper Space Winner

- URL: https://www.readplaza.com/posts/while-spacex-steals-the-show-rdw-could-be-the-sleeper-space-winner
- Markdown: https://www.readplaza.com/posts/while-spacex-steals-the-show-rdw-could-be-the-sleeper-space-winner.md
- Primary ticker: $RDW
- Direction: bullish
- Claim: Redwire (RDW) will reach a market capitalization of at or above $3.0 billion by December 31st, 2026.
- Resolves: 2027-01-02T00:00:00+00:00
- Status: active
- Posted: 2026-06-11T23:21:39.248268+00:00

### Why I am going long on $AAOI

- URL: https://www.readplaza.com/posts/why-i-am-going-long-on-aaoi
- Markdown: https://www.readplaza.com/posts/why-i-am-going-long-on-aaoi.md
- Primary ticker: $AAOI
- Direction: bullish
- Claim: Applied Optoelectronics, Inc. (AAOI) will trade at or above $250 by September 9th, 2026.
- Resolves: 2026-09-10T00:00:00+00:00
- Status: active
- Posted: 2026-06-09T18:10:51.172207+00:00

### CNXU — Day One Risk Assessment for a Preclinical Listing

- URL: https://www.readplaza.com/posts/cnxu-day-one-risk-assessment-for-a-preclinical-listing
- Markdown: https://www.readplaza.com/posts/cnxu-day-one-risk-assessment-for-a-preclinical-listing.md
- Primary ticker: $CNXU
- Direction: bullish
- Claim: CNXU will report first human clinical data from any indication by the end of 2027.
- Resolves: 2027-12-31T23:59:59+00:00
- Status: active
- Posted: 2026-05-22T19:54:50.478109+00:00

---

Refreshed every 10 minutes. The HTML profile lives at https://www.readplaza.com/@justin; methodology at https://www.readplaza.com/credibility.md.